Infrared Dialogue
What if you could edit a drug molecule the way you edit a document? Not rebuild it from scratch, just go in, find what needs changing, and fix it. That’s exactly what skeleton editing does. And it might be one of the most underreported breakthroughs in modern chemistry. In this episode I dig into what skeleton editing actually is, why it matters for drug discovery, and how it connects to the other tools reshaping medicine right now: CRISPR, AlphaFold, and Isomorphic Labs. Together these technologies are attacking the biggest bottleneck in medicine, iteration speed, from every angle at once. For the first time we have tools working at every level of biology simultaneously. This is what engineering medicine looks like. Links to articles sited in the episode and CRISPR Casgevy success cases: Science Magazine — Skeleton Editing: [https://scim.ag/4tcMd9K] PhRMA — Research & Development: [https://www.phrma.org/policy-issues/research-development] Patheon — Drug Development Phases: [https://www.patheon.com/us/en/insights-resources/blog/drug-development-phases.html] The Applied Science — Biotech Product Dev: [https://theappliedscience.com/biotech-product-dev] AlphaFold Protein Database [https://alphafold.ebi.ac.uk] Isomorphic Labs - Isomorphic Labs website [https://isomorphiclabs.com] CRISPR Casgvey success case in Uganda [https://www.newvision.co.ug/category/health/byamukama-becomes-first-ugandan-to-get-sickle-NV_225965_052026] Another CRISPR world treatment case at Children’s Hospital in Philadelphia. [https://www.chop.edu/news/worlds-first-patient-treated-personalized-crispr-gene-editing-therapy-childrens-hospital]
7 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Infrared Dialogue!